Pharma is under the proverbial gun as Trump takes office, but these pharma dividend payers are stocks to buy for the long term More
Pharmaceutical stocks have grown tremendously as medicine advances. With diseases like diabetes and even Ebola affecting more and more of the population, pharmaceutical companies are racing to find cures – further advancing medicine and driving their stock prices up. Corporations like Pfizer (NYSE:PFE) and Gilead Sciences (NASDAQ:GILD) are leading the charge against disease but smaller companies such as Myland (NASDAQ:MYL) are interesting investments as well.
Biotech and pharmaceutical companies headed lower and not because of the election. Here's why you should sell these stocks More
Big pharma has some great long-term drivers, and a wealth of these help power my favorite pharma pick, Eli Lilly. Look to LLY for value More
Investors and analysts are raising their eyebrows over some strange goings on at Valeant Pharmaceuticals, leading to our bear call on VRX stock More
AbbVie Inc is under pressure as the government reviews a patent and competitor Coherus waits in the wings More
With all the talk on the campaign trail about drug costs, it's safe to say the pharmaceutical industry is under siege. But these drug stocks are solid buys More
Between a planned merger with Allergan and a strong pipeline of drugs, PFE stock is a solid choice at a great price. More